Global Monosialotetrahexosylganglioside Market Research Report 2023

Monosialotetrahexosylganglioside Market

Monosialotetrahexosylganglioside is used to treat patients with central nervous system lesions including brain crest trauma, cerebrovascular accident, and Parkinson's disease.

The global Monosialotetrahexosylganglioside market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Monosialotetrahexosylganglioside is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Monosialotetrahexosylganglioside is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Monosialotetrahexosylganglioside in Brain Crest Trauma is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Monosialotetrahexosylganglioside include Qilu Pharmaceutical, Heilongjiang Harbin Medical University Pharmaceutical, Beijing Sihuan Pharmaceutical, Beijing Saisheng Pharmaceutical, Jilin Yinglian Biopharmaceutical, Southwest Pharmaceutical and Changchun Xiangtong Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Monosialotetrahexosylganglioside, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monosialotetrahexosylganglioside.

The Monosialotetrahexosylganglioside market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Monosialotetrahexosylganglioside market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monosialotetrahexosylganglioside companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Monosialotetrahexosylganglioside Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Monosialotetrahexosylganglioside Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Oral Agents

1.2.3 Injection

1.3 Market by Application

1.3.1 Global Monosialotetrahexosylganglioside Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Brain Crest Trauma

1.3.3 Cerebrovascular Accident

1.3.4 Parkinson'S Disease

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Monosialotetrahexosylganglioside Market Perspective (2018-2029)

2.2 Monosialotetrahexosylganglioside Growth Trends by Region

2.2.1 Global Monosialotetrahexosylganglioside Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Monosialotetrahexosylganglioside Historic Market Size by Region (2018-2023)

2.2.3 Monosialotetrahexosylganglioside Forecasted Market Size by Region (2024-2029)

2.3 Monosialotetrahexosylganglioside Market Dynamics

2.3.1 Monosialotetrahexosylganglioside Industry Trends

2.3.2 Monosialotetrahexosylganglioside Market Drivers

2.3.3 Monosialotetrahexosylganglioside Market Challenges

2.3.4 Monosialotetrahexosylganglioside Market Restraints

3.1 Global Top Monosialotetrahexosylganglioside Players by Revenue

3.1.1 Global Top Monosialotetrahexosylganglioside Players by Revenue (2018-2023)

3.1.2 Global Monosialotetrahexosylganglioside Revenue Market Share by Players (2018-2023)

3.2 Global Monosialotetrahexosylganglioside Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Monosialotetrahexosylganglioside Revenue

3.4 Global Monosialotetrahexosylganglioside Market Concentration Ratio

3.4.1 Global Monosialotetrahexosylganglioside Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Monosialotetrahexosylganglioside Revenue in 2022

3.5 Monosialotetrahexosylganglioside Key Players Head office and Area Served

3.6 Key Players Monosialotetrahexosylganglioside Product Solution and Service

3.7 Date of Enter into Monosialotetrahexosylganglioside Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Monosialotetrahexosylganglioside Historic Market Size by Type (2018-2023)

4.2 Global Monosialotetrahexosylganglioside Forecasted Market Size by Type (2024-2029)

5.1 Global Monosialotetrahexosylganglioside Historic Market Size by Application (2018-2023)

5.2 Global Monosialotetrahexosylganglioside Forecasted Market Size by Application (2024-2029)

6.1 North America Monosialotetrahexosylganglioside Market Size (2018-2029)

6.2 North America Monosialotetrahexosylganglioside Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Monosialotetrahexosylganglioside Market Size by Country (2018-2023)

6.4 North America Monosialotetrahexosylganglioside Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Monosialotetrahexosylganglioside Market Size (2018-2029)

7.2 Europe Monosialotetrahexosylganglioside Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Monosialotetrahexosylganglioside Market Size by Country (2018-2023)

7.4 Europe Monosialotetrahexosylganglioside Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size (2018-2029)

8.2 Asia-Pacific Monosialotetrahexosylganglioside Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2018-2023)

8.4 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Monosialotetrahexosylganglioside Market Size (2018-2029)

9.2 Latin America Monosialotetrahexosylganglioside Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Monosialotetrahexosylganglioside Market Size by Country (2018-2023)

9.4 Latin America Monosialotetrahexosylganglioside Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size (2018-2029)

10.2 Middle East & Africa Monosialotetrahexosylganglioside Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2018-2023)

10.4 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Qilu Pharmaceutical

11.1.1 Qilu Pharmaceutical Company Detail

11.1.2 Qilu Pharmaceutical Business Overview

11.1.3 Qilu Pharmaceutical Monosialotetrahexosylganglioside Introduction

11.1.4 Qilu Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023)

11.1.5 Qilu Pharmaceutical Recent Development

11.2 Heilongjiang Harbin Medical University Pharmaceutical

11.2.1 Heilongjiang Harbin Medical University Pharmaceutical Company Detail

11.2.2 Heilongjiang Harbin Medical University Pharmaceutical Business Overview

11.2.3 Heilongjiang Harbin Medical University Pharmaceutical Monosialotetrahexosylganglioside Introduction

11.2.4 Heilongjiang Harbin Medical University Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023)

11.2.5 Heilongjiang Harbin Medical University Pharmaceutical Recent Development

11.3 Beijing Sihuan Pharmaceutical

11.3.1 Beijing Sihuan Pharmaceutical Company Detail

11.3.2 Beijing Sihuan Pharmaceutical Business Overview

11.3.3 Beijing Sihuan Pharmaceutical Monosialotetrahexosylganglioside Introduction

11.3.4 Beijing Sihuan Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023)

11.3.5 Beijing Sihuan Pharmaceutical Recent Development

11.4 Beijing Saisheng Pharmaceutical

11.4.1 Beijing Saisheng Pharmaceutical Company Detail

11.4.2 Beijing Saisheng Pharmaceutical Business Overview

11.4.3 Beijing Saisheng Pharmaceutical Monosialotetrahexosylganglioside Introduction

11.4.4 Beijing Saisheng Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023)

11.4.5 Beijing Saisheng Pharmaceutical Recent Development

11.5 Jilin Yinglian Biopharmaceutical

11.5.1 Jilin Yinglian Biopharmaceutical Company Detail

11.5.2 Jilin Yinglian Biopharmaceutical Business Overview

11.5.3 Jilin Yinglian Biopharmaceutical Monosialotetrahexosylganglioside Introduction

11.5.4 Jilin Yinglian Biopharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023)

11.5.5 Jilin Yinglian Biopharmaceutical Recent Development

11.6 Southwest Pharmaceutical

11.6.1 Southwest Pharmaceutical Company Detail

11.6.2 Southwest Pharmaceutical Business Overview

11.6.3 Southwest Pharmaceutical Monosialotetrahexosylganglioside Introduction

11.6.4 Southwest Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023)

11.6.5 Southwest Pharmaceutical Recent Development

11.7 Changchun Xiangtong Pharmaceutical

11.7.1 Changchun Xiangtong Pharmaceutical Company Detail

11.7.2 Changchun Xiangtong Pharmaceutical Business Overview

11.7.3 Changchun Xiangtong Pharmaceutical Monosialotetrahexosylganglioside Introduction

11.7.4 Changchun Xiangtong Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023)

11.7.5 Changchun Xiangtong Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Monosialotetrahexosylganglioside Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Oral Agents

    Table 3. Key Players of Injection

    Table 4. Global Monosialotetrahexosylganglioside Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Monosialotetrahexosylganglioside Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Monosialotetrahexosylganglioside Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Monosialotetrahexosylganglioside Market Share by Region (2018-2023)

    Table 8. Global Monosialotetrahexosylganglioside Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Monosialotetrahexosylganglioside Market Share by Region (2024-2029)

    Table 10. Monosialotetrahexosylganglioside Market Trends

    Table 11. Monosialotetrahexosylganglioside Market Drivers

    Table 12. Monosialotetrahexosylganglioside Market Challenges

    Table 13. Monosialotetrahexosylganglioside Market Restraints

    Table 14. Global Monosialotetrahexosylganglioside Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Monosialotetrahexosylganglioside Market Share by Players (2018-2023)

    Table 16. Global Top Monosialotetrahexosylganglioside Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monosialotetrahexosylganglioside as of 2022)

    Table 17. Ranking of Global Top Monosialotetrahexosylganglioside Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Monosialotetrahexosylganglioside Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Monosialotetrahexosylganglioside Product Solution and Service

    Table 21. Date of Enter into Monosialotetrahexosylganglioside Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Monosialotetrahexosylganglioside Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2018-2023)

    Table 25. Global Monosialotetrahexosylganglioside Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2024-2029)

    Table 27. Global Monosialotetrahexosylganglioside Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Monosialotetrahexosylganglioside Revenue Market Share by Application (2018-2023)

    Table 29. Global Monosialotetrahexosylganglioside Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Monosialotetrahexosylganglioside Revenue Market Share by Application (2024-2029)

    Table 31. North America Monosialotetrahexosylganglioside Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Monosialotetrahexosylganglioside Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Monosialotetrahexosylganglioside Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Monosialotetrahexosylganglioside Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Monosialotetrahexosylganglioside Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Monosialotetrahexosylganglioside Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Monosialotetrahexosylganglioside Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Monosialotetrahexosylganglioside Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Monosialotetrahexosylganglioside Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Monosialotetrahexosylganglioside Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Monosialotetrahexosylganglioside Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Qilu Pharmaceutical Company Detail

    Table 47. Qilu Pharmaceutical Business Overview

    Table 48. Qilu Pharmaceutical Monosialotetrahexosylganglioside Product

    Table 49. Qilu Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023) & (US$ Million)

    Table 50. Qilu Pharmaceutical Recent Development

    Table 51. Heilongjiang Harbin Medical University Pharmaceutical Company Detail

    Table 52. Heilongjiang Harbin Medical University Pharmaceutical Business Overview

    Table 53. Heilongjiang Harbin Medical University Pharmaceutical Monosialotetrahexosylganglioside Product

    Table 54. Heilongjiang Harbin Medical University Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023) & (US$ Million)

    Table 55. Heilongjiang Harbin Medical University Pharmaceutical Recent Development

    Table 56. Beijing Sihuan Pharmaceutical Company Detail

    Table 57. Beijing Sihuan Pharmaceutical Business Overview

    Table 58. Beijing Sihuan Pharmaceutical Monosialotetrahexosylganglioside Product

    Table 59. Beijing Sihuan Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023) & (US$ Million)

    Table 60. Beijing Sihuan Pharmaceutical Recent Development

    Table 61. Beijing Saisheng Pharmaceutical Company Detail

    Table 62. Beijing Saisheng Pharmaceutical Business Overview

    Table 63. Beijing Saisheng Pharmaceutical Monosialotetrahexosylganglioside Product

    Table 64. Beijing Saisheng Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023) & (US$ Million)

    Table 65. Beijing Saisheng Pharmaceutical Recent Development

    Table 66. Jilin Yinglian Biopharmaceutical Company Detail

    Table 67. Jilin Yinglian Biopharmaceutical Business Overview

    Table 68. Jilin Yinglian Biopharmaceutical Monosialotetrahexosylganglioside Product

    Table 69. Jilin Yinglian Biopharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023) & (US$ Million)

    Table 70. Jilin Yinglian Biopharmaceutical Recent Development

    Table 71. Southwest Pharmaceutical Company Detail

    Table 72. Southwest Pharmaceutical Business Overview

    Table 73. Southwest Pharmaceutical Monosialotetrahexosylganglioside Product

    Table 74. Southwest Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023) & (US$ Million)

    Table 75. Southwest Pharmaceutical Recent Development

    Table 76. Changchun Xiangtong Pharmaceutical Company Detail

    Table 77. Changchun Xiangtong Pharmaceutical Business Overview

    Table 78. Changchun Xiangtong Pharmaceutical Monosialotetrahexosylganglioside Product

    Table 79. Changchun Xiangtong Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2018-2023) & (US$ Million)

    Table 80. Changchun Xiangtong Pharmaceutical Recent Development

    Table 81. Research Programs/Design for This Report

    Table 82. Key Data Information from Secondary Sources

    Table 83. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Monosialotetrahexosylganglioside Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Monosialotetrahexosylganglioside Market Share by Type: 2022 VS 2029

    Figure 3. Oral Agents Features

    Figure 4. Injection Features

    Figure 5. Global Monosialotetrahexosylganglioside Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Monosialotetrahexosylganglioside Market Share by Application: 2022 VS 2029

    Figure 7. Brain Crest Trauma Case Studies

    Figure 8. Cerebrovascular Accident Case Studies

    Figure 9. Parkinson'S Disease Case Studies

    Figure 10. Monosialotetrahexosylganglioside Report Years Considered

    Figure 11. Global Monosialotetrahexosylganglioside Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Monosialotetrahexosylganglioside Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Monosialotetrahexosylganglioside Market Share by Region: 2022 VS 2029

    Figure 14. Global Monosialotetrahexosylganglioside Market Share by Players in 2022

    Figure 15. Global Top Monosialotetrahexosylganglioside Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monosialotetrahexosylganglioside as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Monosialotetrahexosylganglioside Revenue in 2022

    Figure 17. North America Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Monosialotetrahexosylganglioside Market Share by Country (2018-2029)

    Figure 19. United States Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Monosialotetrahexosylganglioside Market Share by Country (2018-2029)

    Figure 23. Germany Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Monosialotetrahexosylganglioside Market Share by Region (2018-2029)

    Figure 31. China Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Monosialotetrahexosylganglioside Market Share by Country (2018-2029)

    Figure 39. Mexico Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Monosialotetrahexosylganglioside Market Share by Country (2018-2029)

    Figure 43. Turkey Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Monosialotetrahexosylganglioside Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Qilu Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2018-2023)

    Figure 46. Heilongjiang Harbin Medical University Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2018-2023)

    Figure 47. Beijing Sihuan Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2018-2023)

    Figure 48. Beijing Saisheng Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2018-2023)

    Figure 49. Jilin Yinglian Biopharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2018-2023)

    Figure 50. Southwest Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2018-2023)

    Figure 51. Changchun Xiangtong Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2018-2023)

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed